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DA-7/IL-24
has
noteworthy
potential as an anticancer therapeutic because of its diversity of antitumor properties, its lack of toxicity toward
normal cells and tissues, and its safety
and efficacy as evidenced in a phase I
clinical trial. In a recent study, we document that Ad.mda-7-induced ER stress
and ceramide production leads to early
autophagy that subsequently switches to
apoptosis in human prostate cancer cells.
During the apoptotic phase, the MDA-7/
IL-24 protein physically interacts with
Beclin 1 and this interaction might
inhibit Beclin 1 function culminating in
apoptosis. Conversely, Ad.mda-7 infection leads to calpain-mediated cleavage of the Atg5 protein that might also
facilitate a biochemical switch from autophagy to apoptosis. Our recent paper
reveals novel aspects of the interplay
between autophagy and apoptosis that
underlie the cytotoxic action of MDA-7/
IL-24 in prostate cancer cells. These
new insights into MDA-7/IL-24 action
provide intriguing leads for developing
innovative combinatorial approaches for
prostate cancer therapy.

autophagy in prostate cancer cells, without affecting normal human prostate epithelial cells, via the canonical autophagic
pathway, involving BECN1, ATG5 and
hVPS34.
MDA-7/IL-24 induces ER stress and
ceramide production and these changes
play a pivotal role in autophagy induction (Fig. 1). We examined the effect
of the ER stress inhibitor salubrinal
and the ceramide inhibitor ISP-1 on
Ad.mda-7-induced autophagy by analyzing LC3-II accumulation 24 h postinfection. Co-treatment of Ad.mda-7-infected
DU-145 cells with noncytotoxic doses
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Ad.mda-7 induces autophagy selectively in different types of human prostate cancer cells, without promoting
this effect in immortal normal human
prostate epithelial cells. We document
that Ad.mda-7-induced ER stress and
ceramide generation result in induction of
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Figure 1. Model illustrating the possible
molecular mechanism of ER stress- and
ceramide-mediated autophagy promoted
by MDA-7/IL-24 that switches to apoptosis in
prostate cancer cells.
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of salubrinal (5 μM) or ISP-1 (10 μM)
significantly inhibit LC3-II accumulation, and a combination of salubrinal and
ISP-1 further reduce Ad.mda-7-induced
LC3-II accumulation. The three major
transducers of ER stress are IRE1, PERK
and ATF6, which all sense the presence of
unfolded proteins and transduce signals
to the nucleus or cytosol. We hypothesized that one or more of these transducers must activate the signaling required
for Ad.mda-7-induced autophagy and
tested this possibility using siRNA targeting IRE1 and ATF6, and with a PERK
dominant negative mutant. Among these
treatments, IRE1 and ATF6 knockdown
cells show no change in GFP-LC3-II
accumulation during a 24 h period after
Ad.mda-7 infection. However, Ad.mda-7
induces punctate staining of GFP-LC3
vacuoles and a dominant negative inhibitor of PERK (Dn-PERK) significantly
inhibits LC3-II accumulation in DU-145
cells. These results suggest a potential
involvement of PERK, an ER stress mediator, in Ad.mda-7-induced autophagy.
Collectively, these observations support
the hypothesis that Ad.mda-7-induced
ER stress and ceramide production might
contribute to autophagy through a PERKdependent pathway in prostate carcinoma
cells.
Cellular stress can promote autophagy
and apoptosis in a number of ways including induction of autophagy/apoptosis
sequentially, simultaneously, or in a mutually exclusive manner. Electron microscopy studies document autophagic features
at 24 h followed by apoptotic features at
48 h post-Ad.mda-7 infection in DU-145
cells. To investigate the potential relationship between autophagy and apoptosis, we
analyzed the growth inhibitory potential
of Ad.mda-7 in DU-145 cells in the presence of the autophagy inhibitor 3-methyladenosine (3-MA). This experiment

indicated that inhibition of autophagy can
sensitize prostate tumor cells to the cytotoxic (apoptotic) actions of MDA-7/IL-24
and Ad.mda-7-induced autophagy might
initially be a cytoprotective mechanism
in prostate tumor cells. Additionally, the
connection between Ad.mda-7-induced
autophagy and apoptosis was investigated
using Bcl-2 and Bcl-x L-overexpressing
DU-145 cells (DU-Bcl-2 and DU-Bcl-x L).
Ad.mda-7-infected
DU-Bcl-2
and
DU-Bcl-x L cells continue to exhibit higher
autophagic phenotypes as compared with
control DU-Neo clones, indicating that
in DU-145 cells, Ad.mda-7-induced autophagy culminates in apoptosis, and when
apoptosis is blocked by overexpression of
Bcl-2 or Bcl-x L autophagy increases. To
further confirm this possibility, we stained
Ad.mda-7-infected DU-145 cells with
MDC and PI and analyzed treated-cells
by flow cytometry 48 h post-infection.
We observed that autophagic cells also
display apoptotic features as revealed by
both MDC and PI staining in 25.8% of
Ad.mda-7-infected cells as compared with
1.9% of Ad.vec-infected cells.
To investigate the role of the autophagy-related genes BECN1 and ATG5 in
Ad.mda-7-induced apoptosis, we knocked
down BECN1 and ATG5 expression with
siRNA in DU-145 cells and examined
Ad.mda-7 sensitivity. Beclin 1-deficient
DU-145 cells exhibit increased sensitivity toward Ad.mda-7 when administered
at 100 pfu/cell. In contrast, silencing of
the ATG5 gene results in only a partial
resistance to Ad.mda-7. These findings
suggest that although at 24 h post-infection, Ad.mda-7 induces Beclin 1 and
ATG5 to facilitate autophagy, at 48 h
there might be inhibition of Beclin 1 and
augmentation of ATG5 that then leads
to apoptosis. During this predominantly
apoptotic phase of Ad.mda-7-treatment
the interaction between Beclin 1 and

MDA-7/IL-24 might inhibit autophagy.
To determine the role of ATG5 in the
predominantly apoptotic phase at 48 h
post-Ad.mda-7 infection, ATG5 mRNA
and protein expressions were analyzed.
At 48 h, Ad.mda-7 infection results in
significant induction in ATG5 mRNA
levels. Although the levels of the ATG5
protein do not significantly change upon
Ad.mda-7 infection, a second band corresponding to a molecular weight 24-kDa
protein is observed in Ad.mda-7-infected
cells. Considering this finding, calpain
activity was measured in Ad.mda-7treated cells by calpain-Glo protease assay.
Calpain activity is significantly higher in
Ad.mda-7-infected cells when compared
with control or Ad.vec-infected cells. Our
study suggests a novel role for Beclin 1 and
ATG5 in mediating a switch between protective autophagy and apoptosis in prostate cancer cells infected with Ad.mda-7.
Based on our recent observations, employing strategies to block autophagy through
promoting ER stress and ceramide production may represent a viable tactic
for enhancing the antitumor activity of
mda-7/IL-24 toward prostate and potentially other cancers.
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